170984-05-1

Upstream product

• 29868-39-1 XZ-150-129-A 
• 98-88-4 benzoyl chloride 

Downstream Products

• 170984-06-2 9-N-[(3',5'-O-(tetraisopropyldisiloxane-1,3-diyl)-β-D-ribo-pentafuranosyl)methyl]-N⁶-benzoyladenine 
• 726186-42-1 9-N-[(5'-O-(4,4'-dimethoxytrityl)-β-D-ribo-pentafuranosyl)methyl]-N⁶-benzoyladenine 
• 726186-38-5 9-N-[(2'-O-(tetrahydrofuranyl)-β-D-ribo-pentafuranosyl)methyl]-N⁶-benzoyladenine 
• 726186-39-6 9-N-[(5'-O-(4,4'-dimethoxytrityl)-2'-O-(tetrahydrofuranyl)-β-D-ribo-pentafuranosyl)methyl]-N⁶-benzoyladenine 

Relevant academic research and scientific papers

Homo-N-oligonucleotides (N1/N9-C1′ methylene bridge oligonucleotides): Nucleic acids with left-handed helicity

Oligonucleotides containing a methylene bridge between N1 or N9 of the heterocyclic base and C1′ of the pentofuranosyl ring (homo-N- oligonucleotides) were synthesized. Melting curves revealed that such homo-type oligomers could cross-pair with complement

Antiviral c-nucleoside derivatives

The present invention is composed of a nucleoside derivative of the following general formula ?I!: STR1 (wherein B represents adenin-9-ylmethyl, guanin-9-ylmethyl, hypoxanthin-9-ylmethyl, thymin-1-ylmethyl, uracil-1-ylmethyl, or cytosin-1-ylmethyl; X and